CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents	$ 1,718,000	$ 698,000
Other current assets	84,000	131,000
Total current assets	1,802,000	829,000
Patent license rights, net	235,000	353,000
Total assets	2,037,000	1,182,000
Current liabilities
Accounts payable	157,000	249,000
Other accrued liabilities	36,000	55,000
Total current liabilities	193,000	304,000
Long-term debt
Convertible Promissary Notes Payable	0	1,000,000
Secured Debt, net of unamortized isuance costs	2,159,000	0
Total long-term debt	2,159,000	1,000,000
Capstone Therapeutics Corp. Stockholders' Equity
Common Stock $.0005 par value; 150,000,000 shares authorized; 54,385,411 and 40,885,411 shares outstanding September 30, 2017 and December 31, 2016, respectively	27,000	20,000
Additional paid-in capital	190,468,000	189,477,000
Accumulated deficit	(190,810,000)	(189,619,000)
Total Capstone Therapeutics Corp. stockholders' equity (deficit)	(315,000)	(122,000)
Noncontrolling interest	0	0
Total equity	(315,000)	(122,000)
Total liabilities and equity	$ 2,037,000	$ 1,182,000